Titlebook: Cystoid Macular Edema; Medical and Surgical Shlomit Schaal,Henry J. Kaplan Book 2017 Springer International Publishing Switzerland 2017 CME

敘述

Introduction termed “cystoid macular edema” (CME), which represents the collection of excess fluid in “cysts” within the neurosensory retina, it is more broadly defined as extracellular accumulation of fluid within the outer plexiform layer of the retina. Thus, CME should be referred to as a subtype of macular

llibretto

Ruptured-Disk

使堅(jiān)硬

Medical Management of CME Associated with Uveitis treatment should be initiated early and continue until complete resolution. Corticosteroids have been the mainstay of therapy and can be given topically, as a periocular or intravitreal injection, via an implantable depot preparation, or orally. Risks of cataract and glaucoma can limit the ongoing

多山

Medical Management of CME Associated with Diabetespathy Study (ETDRS), several trials have evaluated new treatments for DME. Currently, the medical management of DME includes systemic risk factor modification, topical medications, intraocular steroids, and anti-VEGF medications. While the ideal treatment regimen has not been identified, there are s

consolidate

Medical Management of CME Associated with Retinal Vascular OcclusionsVO). The introduction of intravitreal therapy has revolutionized the treatment of macular edema secondary to RVO. Intravitreal anti-VEGF therapy with ranibizumab and aflibercept has been approved for the treatment of RVO. Additionally, sustained-release intravitreal dexamethasone implants have gaine

Demulcent

推延

SLAY

Surgical Management of Diabetic Macular Edemaincreasingly implicated in select patients. Surgical interventions, including vitrectomy, epiretinal membrane (ERM) peel, and internal limiting membrane (ILM) peel, have been proposed in these patients to relieve traction, clear cytokines, and improve oxygenation. This chapter reviews the efficacy o

變化無(wú)常